Eli Lilly Corp. buy UBS Group AG
Start price
24.05.23
/
50%
€397.00
Target price
24.05.24
€462.89
Performance (%)
81.38%
Price
13:04
€716.80
Summary
This prediction is currently active. With a performance of 81.38% the BUY prediction by UBS_Group_AG is a big success. Dividends of €3.29 are taken into consideration when calculating the performance. This prediction currently runs until 24.05.24. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Eli Lilly Corp. | 1.958% | 1.958% |
iShares Core DAX® | 4.015% | 2.971% |
iShares Nasdaq 100 | 2.755% | 0.503% |
iShares Nikkei 225® | -0.826% | -5.057% |
iShares S&P 500 | 2.330% | 0.720% |
Comments by UBS_Group_AG for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE: LLY) had its price target raised by analysts at UBS Group AG from $447.00 to $498.00. They now have a "buy" rating on the stock.
Ratings data for LLY provided by MarketBeat